Published July 14, 2021 by PATH Effective and affordable new research diagnostic tool can measure up to 11 key biomarkers of environmental enteric dysfunction with a single test Quansys Biosciences and global health nonprofit PATH have collaborated to develop a...
For Immediate Release Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be...
For Immediate Release Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2 (4-plex) ELISA Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be used in surveillance studies. Logan, UT, April 8, 2020 — Quansys...
For Immediate Release Contact: scall@quansysbio.com Quansys to present on multiplexing protein biomarkers in Precision Medicine at the 10th Annual, Clinical, Biomarkers & World CDx Conference Logan, UT, August 22, 2019—Quansys Biosciences, Inc. a pioneer in...
PATH and Quansys Biosciences, Inc. improve access of the Q-Plex™ Human Micronutrient Array for low- and middle-income countries with a new price of US$1.43 per analyte SEATTLE, Aug. 20, 2018 — PATH and Quansys Biosciences, Inc., have agreed to reduce the cost of...
Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has...
